← Back to Clinical Trials
Recruiting NCT06058611

NCT06058611 Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06058611
Status Recruiting
Phase
Sponsor Universidad de Zaragoza
Condition Mild Cognitive Impairment
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2024-04-01
Primary Completion 2024-05-01

Trial Parameters

Condition Mild Cognitive Impairment
Sponsor Universidad de Zaragoza
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2024-04-01
Completion 2024-05-01
Interventions
Cognitive stimulationStimulating leisure activities

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of the study is to evaluate, at the level of global cognition, cognitive neuroconstructs, memory, verbal fluency, ADLs, IADLs, symptoms of depression and anxiety, the effectiveness of a personalised and adapted computerised cognitive stimulation programme (GI1) implemented from Primary Care versus stimulating leisure activities (GI2), in older adults aged 50 years and over with mild cognitive impairment and subjective cognitive impairment living in the community.

Eligibility Criteria

Inclusion Criteria: * ≥ 50 years old, resident in the community. * Diagnosis of MCI or having between 24 and 27 points on the MEC-35 (this score seems to indicate the presence of MCI) (Calero, M. D and Navarro, 2006). * Subjective cognitive impairment (score between 28-31 points on the MEC-35) (Gómez-Soria et al. 2023) Exclusion Criteria: * Institutionalisation. * Taking acetylcholinesterase inhibitors as they may act on global cognition and/or cognitive functions. * Sensory deficits (deafness and blindness) preventing intervention. * Agitation. * Having received cognitive stimulation in the last 12 months.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology